CMAC
Home
Journal Archive
Subscription
About
About
Author Guidelines
Editorial Board
Peer Review
Publishing Ethics
English
Русский
Nataly V. Ivanchik
ORCID:
0000-0002-9392-0732
Natali.Ivanchik@antibiotic.ru
Latest
Antimicrobial susceptibility of
Moraxella catarrhalis
in Russia: results of the PEGAS 2010–2021 multicenter study
Clinical Microbiology and Antimicrobial Chemotherapy. 2024; 26(2):188-193
Antimicrobial resistance of clinical isolates of
Klebsiella pneumoniae
and
Escherichia coli
in Russian hospitals: results of a multicenter epidemiological study
Clinical Microbiology and Antimicrobial Chemotherapy. 2024; 26(1):67-78
In vitro
activity of cefpodoxime against Russian clinical isolates of
Haemophilus influenzae
,
Streptococcus pneumoniae
and
Streptococcus pyogenes
Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(4):372-378
Microbiologic diagnosis of community-acquired urinary tract infections: official statements of the board of experts
Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(3):221-224
Current methods of capsular typing of
Streptococcus pneumoniae
: possibilities and availability for local laboratories
Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(1):61-66
In vitro
activity of biapenem and other carbapenems against Russian clinical isolates of
Pseudomonas aeruginosa
,
Acinetobacter
spp., and
Enterobacterales
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3):280-291
Susceptibility of clinical
Enterobacterales
and
Pseudomonas aeruginosa
isolates to ceftazidimeavibactam in Russia: multicenter local laboratory databased surveillance
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3):264-278
Official statements of the board of experts on the use of topical thiamphenicol in patients with communityacquired respiratory infections
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(2):195-196
The prevalence and antimicrobial susceptibility of circulating
S. pneumoniae
serotypes in adult population in Russia (epidemiological study «SPECTRUM»)
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(2):127-137
In vitro
activity of thiamphenicol against
Haemophilus influenzae
,
Streptococcus pneumoniae
and
Streptococcus pyogenes
clinical isolates
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(1):92-99
The genetic characteristics of
Neisseria meningitidis
causing invasive meningococcal infections in Smolensk region
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(2):92-95
Antimicrobial resistance of clinical
Streptococcus pyogenes
isolates in Russia: the results of multicenter epidemiological study «PEHASus 2014–2017»
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(1):40-45
Antimicrobial resistance of
Haemophilus influenzae
clinical isolates in Russia: the results of multicenter epidemiological study «PEHASus 2014–2017»
Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(4):317-323
The prevalence of circulating
S. pneumoniae
serotypes in people older than 18 years: healthy carriers, patients with acute otitis media, community-acquired pneumonia, and invasive pneumococcal infections (epidemiological study «SPECTRUM»)
Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(4):275-281
Antimicrobial resistance of clinical
Streptococcus pneumoniae
isolates in Russia: the results of multicenter epidemiological study «PEHASus 2014–2017»
Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(3):230-237
Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial
Acinetobacter
spp. isolates in Russia: results of multicenter epidemiological study ”MARATHON 2015–2016”
Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):171-180
Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial
Pseudomonas aeruginosa
isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”
Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):160-170
Antimicrobial resistance of nosocomial
Enterobacterales
isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”
Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):147-159
Comparison of
in vitro
activity of various macrolides against
Helicobacter pylori
Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(3):192-197
Susceptibility testing of
Candida glabrata
clinical strains to echinocandins using SensititreTM YeastOneTM system
Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):49-54
Antimicrobial resistance of
Helicobacter pylori
in Smolensk
Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):42-48
Antimicrobial resistance of nosocomial
Staphylococcus aureus
isolates in Russia: results of multicenter epidemiological study «MARATHON» 2013-2014
Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(1):57-62
Antimicrobial resistance of nosocomial
Enterobacteriaceae
isolates in Russia: results of multicenter epidemiological study «MARATHON» 2013-2014
Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(1):49-56
Antimicrobial resistance of nosocomial
Acinetobacter spp.
isolates in Russia: results of multicenter epidemiological study «MARATHON» 2013-2014
Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(1):42-48
Antimicrobial resistance of nosocomial
Pseudomonas aeruginosa
isolates in Russia: results of multicenter epidemiological study «MARATHON» 2013-2014
Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(1):37-41
In vitro
Ceftaroline Activity against Major Bacterial Pathogens n Russia: Results of Multicenter Study
Clinical Microbiology and Antimicrobial Chemotherapy. 2015; 17(3):217-226
Antimicrobial Resistance of Nosocomial
Staphylococcus aureus
Isolates in Russia: Results of National Multicenter Surveillance Study «MARATHON» 2011–2012
Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(4):280-286
Antimicrobial Resistance of Nosocomial
Pseudomonas aeruginosa
Isolates in Russia: Results of National Multicenter Surveillance Study «MARATHON» 2011–2012
Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(4):273-279
Antimicrobial Resistance of Nosocomial
Acinetobacter spp.
Isolates in Russia: Results of National Multicenter Surveillance Study «MARATHON» 2011–2012
Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(4):266-272
Antimicrobial Resistance of Nosocomial
Enterobacteriaceae
Isolates in Russia: Results of National Multicenter Surveillance Study «MARATHON» 2011–2012
Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(4):254-265
Antimicrobial Resistance of
Haemophilus influenzae
in Russia: Results of Multicenter Study «PeGASus»
Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(1):57-69
Antimicrobial Resistance of the Respiratory Strains of Streptococcus pyogenes in Russia During 1999–2009
Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(4):309-321
Antimicrobial Resistance of
Streptococcus pneumoniae
in Russia over the 1999–2009: Results of Multicenter Prospective Study PEHASus
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(4):329-341
Antimicrobial Resistance of
S. aureus
Isolated from Infants with Skin and Soft Tissue Infections
Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(4):356-361
Antimicrobial Resistance of Nosocomial Strains of
Escherichia coli
in Russian Hospitals
Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(2):161-169
Antimicrobial Susceptibility of Causative Agents of Fatal Community-Acquired Pneumonia in Adult Patients
Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):368-380
Comparative Efficacy of 0.75% Chloramphenicol Ointment and 2% Mupirocin Ointment in the Treatment of Community-Acquired Skin and Soft Tissue Infections
Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(1):57-65
Cite
×